[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hypertension-pulmonary-arterial\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hypertension-pulmonary-arterial":56},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,37],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":36},"100171170",false,"NCT01501838","Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires","PH-HIBA","* Inclusion Criteria:\n\n  1. Diagnosed with PAH WHO group 1 (2022 ESC\u002FESR guidelines criteria) as the presence of a mean pulmonary artery pressure (mPAP) greater than 20 mmHg at rest with pulmonary arterial wedge pressure (PAWP) \\>15 mmHg and pulmonary vascular resistance (PVR) \\>2 WU, according to the 2022 ESC\u002FERS Guidelines for the diagnosis and treatment of pulmonary hypertension.\n  2. Included in the institutional registry of PAH of Hospital Italiano de Buenos Aires\n  3. Aged ≥18 years at the index date.\n* Exclusion Criteria History of lung transplantation surgery previously the baseline period","ALL","17 Years",{"count":18,"type":19},200,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.",[23],"Hypertension, Pulmonary Arterial","RECRUITING","2025-08-19",{"date":27,"type":28},"2025-08-24","ACTUAL",{"date":30,"type":28},"2017-01-01",{"date":32,"type":19},"2031-06-01",{"name":34,"class":35},"Hospital Italiano de Buenos Aires","OTHER",1,{"id":38,"slug":4,"hasResults":10,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":4,"eligibilityCriteria":42,"healthyVolunteers":10,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":43,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":40,"conditions":44,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":49,"completionDateStruct":51,"leadSponsor":53,"locationsCount":36},"100595988","NCT07039604","Real-World Study of PADN for the Treatment of PAH","Real-World Study of Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Arterial Hypertension (PAH)","Inclusion Criteria:\n\n1. Diagnosed with PAH and received PADN procedure since March 2024.\n2. No contraindications to procedure.\n3. Able to provide informed consent and authorize use of health\u002Fresearch data.\n4. Compliant with treatment and follow-up requirements.\n\nExclusion Criteria:\n\nNone specified.",{"count":18,"type":19},[45,23],"Pulmonary Hypertension","2025-06-17",{"date":48,"type":28},"2025-06-26",{"date":50,"type":28},"2025-03-19",{"date":52,"type":19},"2028-12-30",{"name":54,"class":55},"Pulnovo Medical (Wuxi) Co., Ltd.","INDUSTRY",""]